Current and future biomarkers for pancreatic adenocarcinoma

Sven H. Loosen, Ulf P. Neumann, Christian Trautwein, Christoph Roderburg, Tom Luedde*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number692231
Pages (from-to)1-11
Number of pages11
JournalTumor Biology
Volume39
Issue number6
DOIs
Publication statusPublished - 15 Jun 2017

Keywords

  • MicroRNAs
  • macrophage inhibitory cytokine 1
  • PAM4
  • gemcitabine
  • FOLFIRINOX
  • human equilibrative nucleoside transporter 1
  • EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1
  • RAS GENE MUTATION
  • MACROPHAGE INHIBITORY CYTOKINE-1
  • PACLITAXEL PLUS GEMCITABINE
  • NUCLEAR-RNA FRAGMENTS
  • SERUM TUMOR-MARKERS
  • CANCER-CELL-LINES
  • DUCTAL ADENOCARCINOMA
  • DIFFERENTIAL-DIAGNOSIS
  • PROGNOSTIC-FACTORS

Cite this

Loosen, S. H., Neumann, U. P., Trautwein, C., Roderburg, C., & Luedde, T. (2017). Current and future biomarkers for pancreatic adenocarcinoma. Tumor Biology, 39(6), 1-11. [692231]. https://doi.org/10.1177/1010428317692231